DAM
ZBH icon

Deimos Asset Management’s Zimmer Biomet ZBH Stock Holding History

Deimos Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,090
Closed -$320K – 128
2016
Q1 		$320K Buy
+3,090
New +$299K 0.24% 92

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Deimos Asset Management's ZBH Position: Q2 2016 in Review

Deimos Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2016, closing a stake of 3,090 shares — an estimated $320K sold.

Deimos Asset Management first reported a position in ZBH in Q1 2016 and held it in 1 quarter. The position peaked at $320K in Q1 2016. 765 funds tracked by Wall St. Rank hold ZBH as of Q2 2016.

  • Deimos Asset Management reported no remaining Zimmer Biomet position as of Q2 2016 after selling out during the quarter.
  • Deimos Asset Management sold 3,090 Zimmer Biomet shares in Q2 2016, an estimated $320K.
  • Deimos Asset Management first reported a position in Zimmer Biomet in Q1 2016 and held it in 1 quarter.
  • Deimos Asset Management's Zimmer Biomet position peaked at $320K in Q1 2016.
  • 765 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2016.

Based on Deimos Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.